20.1 IVC Filter Placement, Retrieval & Management

Key Takeaways

  • Consider filtration when acute VTE and a contraindication to therapeutic anticoagulation create an indication. Selected recurrent PE can require separate review.

  • Map the actual anatomy and verify patency, alignment, diameter and model-specific delivery limits.

  • Infrarenal is the usual position. Infrarenal clot, compression or variants can affect evaluation for a suprarenal plan.

  • Set up structured follow-up at placement and reassess removal promptly once protection is no longer needed.

  • Clot, embedding, tilt or fracture can change retrieval risk. Follow the model requirements and support urgent evaluation if bleeding is suspected.

Last updated: November 2026

20.1 IVC Filter Placement, Retrieval & Management

Clinical Core: An inferior vena cava (IVC) filter can intercept venous thrombus before it reaches the lungs. Use depends on the indication, anticoagulation plan and patient risk. The technologist confirms the device, anatomical measurements, placement images and follow-up details.

When filtration is considered

Anticoagulation is the main treatment for most acute venous thromboembolism (VTE). A filter can reduce short-term recurrence risk in selected patients with acute pulmonary embolism (PE) who cannot receive anticoagulation. The 2020 Society of Interventional Radiology (SIR) guideline also supports considering a filter in selected acute deep vein thrombosis (DVT) cases with contraindications, based on clinical risk. Active major bleeding can create such a contraindication. A filter does not treat the existing clot and the team reassesses when drug therapy can be resumed.

Clinical settingGuideline approach
Acute PE and a contraindication to anticoagulationFiltration can be useful. The 2026 U.S. multisociety PE guideline favors a retrievable device when the team decides a filter is necessary.
Acute proximal DVT and a contraindication to anticoagulationConsider a filter according to clinical risk and the treatment plan.
Acute PE on therapeutic anticoagulationThe 2026 guideline recommends against routine filter placement.
Documented recurrent PE despite optimal therapeutic anticoagulationVerify the diagnosis and assess adherence, drug exposure and causes. The 2020 SIR guideline discourages routine use for recurrent VTE. In the narrower scenario of recurrent PE despite optimal therapy in categories B–E, the 2026 guideline allows case-specific filter consideration.
Trauma or major surgery without known acute VTEThe SIR guideline advises against routine primary prophylactic placement.

Permanent devices are designed for indwelling use. A retrievable model includes a design and specified tools for possible removal. When a retrievable device is placed, document who will follow the patient, the indication and how the team will reassess retrieval. The FDA urges removal consideration once protection is no longer needed. An FDA-authored decision model found that, once transient PE risk passed in its cohort assumptions, the balance began to favor removal between days 29 and 54. That range is a model result. The 2026 PE guideline calls for a retrieval attempt as soon as risk has sufficiently decreased and anticoagulation is tolerated.

Before deployment

Review prior imaging and identify the planned venous route and landing zone. A compatible system can use the internal jugular or common femoral vein. Confirm patency and any clot along the chosen path. Use the specific manufacturer's configuration and imaging requirements. For example, the Denali femoral instructions require venacavography to confirm the implant site and describe contrast delivery through the dilator. Other systems can have different accessories. Apply the pressure and flow limits of the actual disposable and ordered injection.

The landmarks are the iliac confluence, major renal vein entries and the segment in which all deployment elements must fit. Use a suitable calibrated image or labeled sizing method to measure the intended landing segment. Look for caval thrombus, compression and variant anatomy such as duplicated cava and a retroaortic or circumaortic renal vein. The more caudal important renal venous entry can alter the infrarenal plan. A duplicated cava can leave a parallel embolic route if filtration addresses only one channel.

What the team verifiesWhy it matters
Access route and delivery modelJugular and femoral configurations can differ in orientation and component compatibility.
Measured landing-zone diameterMatch the model’s labeled range. A filter intended for a smaller segment may fail to appose the wall or may migrate.
Renal venous entries and parallel cavaThe usual infrarenal position must account for the true draining anatomy. The provider can consider an alternative plan in selected variants.
Thrombus or compressionA clot or an unsuitable infrarenal segment can change the route and landing plan.

Worked sizing check. A calibrated measurement is 32 mm at the planned landing zone. The Denali label disallows diameters above 28 mm, and Cook's U.S. Celect Platinum specifications give a maximum of 30 mm. Neither of those models fits that segment. Report the measurement and confirm the labeled options and anatomy with the operator. The measurement alone does not prescribe another implant. Bilateral iliac placement has been reported in selected cases with a large cava and requires specialist evaluation.

Infrarenal and suprarenal planning

Infrarenal placement is usual. Align the filter relative to the lowest relevant renal vein and the intended landing segment using the specified instructions. For example, the Denali femoral labeling specifies placing its snare hook 1 cm below the lowest renal vein. Selected patients with infrarenal thrombus, compression or duplicated channels may warrant assessment of a suprarenal landing zone. Pregnancy adds patient-specific physiological, imaging and device constraints. Review the model instructions and the actual risks. Some filters lack established safety or effectiveness in these settings.

Record the implant model, location, appearance and relevant anatomy. Verify expansion and position with the operator and retain images for follow-up.

Retrieval and complications

For an appropriate retrievable model, standard removal often uses a snare introduced from the jugular route to engage the retrieval hook. A sheath encloses the filter for removal with the specified technique. Review the model and procedural imaging for clot, tilt, embedding or fracture. Assess the amount and location of thrombus, model restrictions and the patient's ability to tolerate the procedure. For example, the Denali instructions advise against retrieval with significant thrombus in or near the filter. The SIR guideline discourages routine separate preprocedure imaging in unselected cases. Follow the model's intraprocedural imaging requirements and the clinical plan for more complex cases.

If a filter cannot be captured or released safely with standard methods, the team reevaluates benefit and risk. Specialized options include loop-snare or forceps techniques and the FDA-authorized CavaClear Laser Sheath for suitable adherent filters after prior methods fail. Its restrictions include clot in the filter or surrounding veins, an inaccessible filter and a nonmetal filter. Report resistance or evidence of injury promptly.

An indwelling filter can fracture, migrate, tilt, penetrate the wall or develop thrombus. Report where a component projects and whether comparison images show change. Symptoms and suspected injury guide evaluation. If retroperitoneal bleeding is suspected after an intervention, report instability and start the emergency response immediately. CT with IV contrast or CT angiography can help characterize suspected bleeding when transport and imaging are appropriate. Continuing instability may require urgent angiographic or surgical evaluation for source control. Follow the procedure-specific response discussed in the hemorrhage lesson.

Loading diagram...
IVC Filter Placement and Retrieval Decisions
Test Your Knowledge

Which case most clearly warrants consideration of an IVC filter under the U.S. VTE guidance?

A

Acute proximal leg DVT and active major bleeding that precludes therapeutic anticoagulation.

B

Acute proximal leg DVT that can be treated with therapeutic anticoagulation.

C

Elective orthopedic surgery without known acute VTE.

D

Remote provoked DVT with completed treatment and no current VTE.

Test Your Knowledge

A calibrated image measures 32 mm at the intended infrarenal landing zone. The proposed Denali filter is not labeled for diameters above 28 mm. How should the team use this information?

A

Use the proposed filter because cava size is unrelated to apposition.

B

Flag the mismatch and reassess the labeled model and landing alternatives before any deployment.

C

Subtract the full diameter from the sheath French size to test compatibility.

D

Treat the measurement as a venous spasm and increase the programmed injection pressure.

Test Your Knowledge

The team has already decided an IVC filter is indicated. Which finding can prompt evaluation for a suprarenal landing site?

A

Patent infrarenal cava with a suitable labeled landing segment and conventional renal venous anatomy.

B

An uncomplicated remote radial arterial puncture.

C

Thrombus occupies the proposed infrarenal landing segment and reaches the lowest renal vein entry.

D

A central venous pressure within the patient's baseline range.

Sections you finish are checked off in the contents.